Subject(s)
Flow Cytometry/trends , Single-Cell Analysis/methods , Aptamers, Nucleotide , Biomarkers , Databases as Topic , Flow Cytometry/instrumentation , Flow Cytometry/standards , Genomics , Humans , Mass Spectrometry/instrumentation , Mass Spectrometry/methods , Microbiota/genetics , Microscopy, Fluorescence , Reproducibility of Results , Software , Validation Studies as TopicABSTRACT
Flow cytometry is increasingly recognized as an invaluable technology in biomarker research. Owing to its multiparametric nature it can provide highly detailed information on any single cell in a heterogeneous population. Its versatility means it can be conducted in both the preclinical and clinical setting, generating biomarker data that can drive decisions pertaining to dose selection in clinical trials, treatment options for cancer sufferers and even suitability of patients to receive transplants. Most tissue types can be utilized by the flow cytometrist, allowing the technology to be applied to many fields of research, yet consensus still needs to be reached on standardization, regulation and validation of multiparametric flow cytometry assays. In parallel, continual innovation in analysis software to manage the huge datasets that can be generated is also needed. Nevertheless, the flexibility of flow cytometry means that it remains at the forefront of both routine and exploratory biomarker studies.